chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Her results were negative; 'chills and fever' nonstop until today and it is getting worse; chill; This is a spontaneous report from a non-contactable consumer via medical information team. A 80-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot number: not reported) via an unspecified route of administration on 10Feb2021 as single dose for covid-19 immunisation. On the night of 14Feb2021, the patient started to feel chills and fever nonstop until today and it was getting worse. The patient took a covid test, because during the week before the patient had been receiving physical therapy and they suspected that she had been infected. The results were negative. The doctor asked them to go to the ER for treatment. The patient did not lost taste or smell. The patient underwent lab tests and procedures which included oxygen levels have been between 95-97% and only once did it go down to 93%. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a registered nurse concerning a 62 year old female teacher with asthma, Grave's disease, hypothyroidism, hypertension, sleep apnoea, possible seizures, possible transient ischaemic attack, haematuria, allergic reaction to antibiotics, penicillin allergy and allergies to LOMOTIL and PROMETRIUM who on 07-JUN-2007 was vaccinated SC in the left upper arm with a single first dose of Zostavax (Oka/Merck) (lot # 657764/0584U).  Concomitant therapy included aspirin, MOBIC, lisinopril-HCTZ (MSD), SYNTHROID, rizatriptan benzoate (MSD), ULTRACET as needed, ADVAIR as needed, PROVENTIL as needed, FLONASE as needed, ESTRACE and estradiol vaginal cream.  Three days after vaccination on 10-JUN-2007, the patient developed a macular, red and flat rash over the chest and legs which caused itching and burning.  The nurse was unable to determine the number of lesions.  Unspecified medical attention was sought.  At the time of the report, the patient had recovered.  Additional information is not expected.
Fever, Fatigue, Weakness, Body Aches, Chills, Muscle Pains lasting until Monday 12/21/2020
My arm was red, swollen, hot to touch and swelled up about 1 inch around the injection site. I still have about a pea size knot there.  It doesn't bother me unless I bump that spot.
Patient became very pale eyes rolled behind head and was unable to keep head up. Fainted for a few seconds before waking up again.
Red itchy rash, sore arm, slightly swollen. Rash got bigger after a couple days Still present and itchy
Patient falsified DOB when registering for vaccination, stating the minor was 09/26/2004. Guardian, consented to the vaccination. Health clinic verified with statistical records that the patients actual DOB is 09/26/2005 which made the vaccine a contraindication.  No known adverse reactions noted.
At the end of May 2020 I started noticing that my hair on my head started falling out. I then noticed it started falling out all over the rest of my body. I started seeing a dermatologist June 22, 2021.
The patient experienced no symptoms; on 6/12/2020 a patient was administered an improperly stored dose of VARIVAX; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concurrent condition, pertinent medical history or drug reactions/allergies was not provided.  On 12-JUN-2020, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # S031496, expiration date 07-OCT-2021) (strength, dose schedule and anatomical site of injection not reported) subcutaneously for prophylaxis (product storage error). The sterile diluent (manufacturer unknown) (lot # T000494, expiration date 06-JUL-2022) used for administration of the dose was properly stored.  The administered dose of the vaccine experienced a temperature of 43.8 Fahrenheit degrees for 29 hours and 30 minutes recorded by a data logger. The patient experienced no symptoms. There was no previous temperature excursion. No product quality complaint involved.
no spike protein based on lab test; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (no spike protein based on lab test) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 004M20A) for COVID-19 vaccination.     No medical history were reported. .    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (no spike protein based on lab test). At the time of the report, VACCINATION COMPLICATION (no spike protein based on lab test) outcome was unknown.            Patient started T-CHOP chemo on 26-Feb-2021. concomitant medications were not given . Treatment information were not provided. No lab data has been provided by the reporter.
Large reddened splotch around injection site that appeared 10 days post injection. Disappeared in 2-3 days
Pt was given MMR vax lt deltoid area when devel sudden swelling & induration, ice to site, DPH when got home;
Chronic urticaria all over body comes and goes through out the day. I have never had anything like this or any allergies prior to getting the Moderna booster
My arm was a little sore. I got a funny headache in mid July that I could control with enough medicine. The headaches wouldn't go away and it started lasting so long. I called my doctor and she sent me for and MRI and the results came back fine. My MD is sending me now to a headache clinic to see if they can assist with the headaches. I started drinking a lot of water and taking Motrin but the headaches never fully go away.
My mother began feeling achy, very uncomfortable, unable to eat. By Thursday she was hospitalized with uncontrollable high blood pressure and a potassium level of 2.9. This was precipitated by the DTAP vaccine given by Dr.
5-10 seizure generalized tonic/clonic 24 hr after DTaP, IPV, Prevnar, Hep B/Hib
subject had a mild case of COVID after weeks of getting the second dose; subject had a mild case of COVID after weeks of getting the second dose; This is a spontaneous report from a contactable consumer (patient).   A 58-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unknown date in May2021 at dose 2, single and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at dose 1, single for COVID-19 immunization. The patient medical history and concomitant medication were not reported. Patient receive any other vaccines within 4 weeks prior to the COVID vaccine was unknown. Prior to vaccination, patient was diagnosed with COVID-19 was unknown. After the vaccination patient had been tested positive for covid-19. Patient had a mild case of COVID after weeks of getting the second dose. The outcome of event was unknown.  Information on lot/batch number has been requested.
Fatigue; Chills/shivering; Headache; Body rash; Off label use; A third (booster) dose was administered.; This is a spontaneous report from a non-contactable pharmacist. A 77-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 28Sep2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 29Sep2021, the patient experienced fatigue, chills/shivering, headache and body rash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, chills/shivering, headache and body rash was resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Patient was given the shot around 1:30-1:45 and was advised to sit after for 15 minutes in case of any effects from the vaccine. she was seated when I noticed her head tilt over and eyes closed and she fainted. I ran over to her to catch her as she was slipping and she came back into conscious within less than a 30 seconds. She was sweating and was very hot. She was alarmed and anxious. I took her BP after she relaxed a bit and drank water and it was 128/86 and HR of 64. She was breathing properly. Just was really hot and sweating. We took her to a room to remove her mask and sit in front of the fan. The EMT's came in and took her to the ambulance to do a full vitals evaluation. She was then cleared to leave.
w/in 3-5 mins of vax pt stated felt a little lightheaded; while getting cool cloth pt fainted & fell in the floor, hitting head on the floor;
69y.o. female who presents for dyspnea. She has known history of gallbladder cancer and prior cholecystectomy, COPD on chronic home oxygen at 2-3L, and recent admission for right intertrochanteric femur fracture status post intramedullary nail placement. She started feeling short of breathing about 3 days prior to arrival. Denies any sick contacts. Has been vaccinated for covid-19. She was having productive cough. She was having chest discomfort with coughing. No fevers noted. She had chills. Denies nausea or vomiting. She presented to the ER for further evaluation. Covid testing returned positive. Chest x-ray showed infiltrates. Mild troponin elevation noted. Mild anemia and leukopenia noted. DC today to home. stable condition.  Discharged with Augmentin to complete total of 5 days for CAP
27OCT97 adm to hosp aseptic meningitis, fever 102, fussy, lethargy, cult negative;
DRY COUGH; SORE THROAT; RUNNY NOSE; FEVER; HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUL-2021, the subject experienced dry cough. On JUL-2021, the subject experienced sore throat. On JUL-2021, the subject experienced runny nose. On JUL-2021, the subject experienced fever. On JUL-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dry cough, fever, sore throat, headache and runny nose was not reported. This report was non-serious.
pt broke out in a pruritic macula papular rash about 4hr p/vax on trunk & upper extremities;given claritin;
Patient presented to ems with light headedness. Patient taken into hallway for evaluation, patient stated they started to feel dizzy and lightheaded. patient history of anxiety, patient thinks it may be due to anxiety but would feel more comfortable getting evaluated. First set of vitals patient was hypertensive 153/99 & tachycardic 120, all other vitals within normal limits, patient layed on stretcher and was given water, after conversating with the patient to try and get his mind off the vaccine scenario, patient vitals reassessed every five minutes, blood pressure and heart rate started going down to his normal range, patient states he has a history of high blood pressure & does not take any medication to control it, patient states he is feeling better & is comfortable enough to walk out and drive home,  patient declined further monitoring, patient explained if anything changes to seek medical help. Patient states transport not necessary at this time.
Crying, irritable, headache, dizziness, nauseous, stomach ache.
Due date May 12th 2021. Uneventful pregnancy then first vaccine shot given 4/16/21. One week later, 37.3 weeks, during a routine prenatal visit increase amniotic fluid was noted. Two weeks later, 38.3 weeks, amniotic fluid increase more. Patient was sent to hospital for an induction. Baby was delivered on May 1 with no complications.
Patient experienced a sore arm and dizziness five minutes after receiving the vaccine. He never lost consciousness. He reported having not eaten anything since 6PM the night before. Patient was given food and water and recovered after about 30 minutes.
Information has been received from a pharmacist referring to a 70 year old female patient. The patient had no pertinent medical history and was allergic to CIPRO, doxycycline, erythromycin and sulfa drugs. On 18-MAY-2016 the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml, subcutaneous, lot#L031272, expiration date 19-NOV-2016). Concomitant therapies included sertraline hydrochloride and hydrochlorothiazide, BENICAR HCT. On 16-JUN-2016 (reported as 7 or 8 days ago), the patient developed a rash on her left hip. The patient visited her physician, who diagnosed the rash as shingles. The reporting pharmacist reported there were no blisters present at the site of the rash. No lab diagnostics studies were performed. Acyclovir was given as treatment. At the time of this report the patient had not recovered from the shingles. Additional information has been requested.
This spontaneous report as received from a nurse refers to a unspecified number of patients in their 30's of unknown gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with ZOSTAVAX 19400 PFU. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. No adverse events were reported. Additional information has been requested.
5 hours after administration chills. Six hours after violently shaking, unable to get warm. Seven hours later temp 104.2 degrees on mercury thermometer and 103.8 on digital. Tylenol taken. Eight hours later unable to move due to shivers and shaking.  Husband and son believe should go to hospital, I did not lose consciousness so refused. Saturday 1AM temp not budge took Advil 400 mg by 0600 temp to 102. All day Saturday taking Advil 400 mg every 5 hours temp 102 and feeling wiped out. Sunday able to move around temp 101 with Advil. Monday AM temp 100 with out Advil-need to take day off of work. And since vaccination have had a feeling of nausea I can't shake. Today -three days later able to eat some but nausea continues.
Um, this vaccine is not recorded anywhere as received at this pharmacy. And this is not the only pharmacy I received a vaccine for COVID. I have received 5 vaccines for COVID. Only two are recorded as received.  This was reported to the CDC, FDA, HHS, and many government agencies. I was passed on to the next place and written off as not useful information. Some referred me to my state hhs. They owe me $96,000 in unemployment and left me homeless with zero COVID assistance over the pandemic. So, I'm not contacting them about nothing!
hive on cheek; injection site warmth; injection site itchiness; 2.5 x 2.5 red area; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hive on cheek), VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE ERYTHEMA (2.5 x 2.5 red area) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20a) for COVID-19 immunisation.     Concomitant products included LEVOTHYROXINE and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE ERYTHEMA (2.5 x 2.5 red area). On an unknown date, the patient experienced URTICARIA (hive on cheek), VACCINATION SITE WARMTH (injection site warmth) and VACCINATION SITE PRURITUS (injection site itchiness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at an unspecified dose and frequency. At the time of the report, URTICARIA (hive on cheek), VACCINATION SITE WARMTH (injection site warmth), VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE ERYTHEMA (2.5 x 2.5 red area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Received H1N1 injection & waited 15 min. without incident.  After returning to classroom, teacher reported child was sleepy & lethargic.  No breathing problems.  VS good, Temp 100.2 & c/o stomach hurting.  Referred to private MD.  In school next day with no problems.
Not sure which type of flu shot exactly. Broke out in hives from buttocks down to feet noticed about 3 hours after flu shot was administered. Took Benadryl right away to prevent spread.
High fever 103.2. Lasted two days than 10 days prior, low grade fever for full 10 days of 100.8. A rash all over body. Dry red bumps. Jerking in sleep 10 days. Confused. Was hospitalized. Hematuria.
Initial information received on 13-Sep-2018 regarding an unsolicited valid non-serious case received from other health professional. This case involves a four months old male patient who was vaccinated with a 0.5 ml third dose of PENTACEL (lot number: C5408AA (liquid) (lot number: C5543AA) (cartoon); expiry date:08-Sep-2019) (route of administration was not reported) in the left thigh on 13-Sep-2018. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patients concomitant medications included ROTATEQ for Immunisation; and PREVNAR 13 for Immunisation. It was a case of actual medication error due to inappropriate reconstitution technique. No adverse reactions have been reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none
she experienced dizziness; dry cough; Headache; Sneezing; No taste; Nausea; Extremely tired; This is a spontaneous report from a contactable consumer (patient).  A 76-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 28Jan2021 (Batch/Lot number was not reported), age at vaccination of 76-years-old, as single dose for covid-19 immunisation. The patient medical history was and concomitant medications were not reported. Between the first shot (28Jan2021) and the second shot (on 18Feb2021), the patient experienced dizziness, dry cough, headache, sneezing, no taste, nausea, and was very tired/ extremely tired.  Outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Achiness (especially in legs), headache the first two days, low grade fever (between 99-100) for 12 days
Patient states her arm was sore after receiving the vaccine on 10/9/17, but her soreness has lingered since then. She reported the discomfort to the pharmacy on 12/15/17 and was advised to reach out to her primary care provider for further evaluation.
This spontaneous report as received from a physician regarding himself refers to a 58 year old male patient. No information about medical history, concurrent conditions and concomitant medications were reported. The reporter stated that he was vaccinated with VARIVAX lot K004419, expiration date 31-MAR-2016, dose 0.5 ml, route subcutaneous instead of ZOSTAVAX, and the next day developed a cough. The outcome of he was inadvertently administered VARIVAX instead of ZOSTAVAX is unknown and the outcome of the cough was reported as not recovered/not resolved. The patient sought medical attention. No product quality complaint was involved. Additional information has been requested.
Patient received extra primary dose of Pediatric Pfizer Lot#: FT1551 instead of Pfizer Bivalent. Parents notified and informed child qualifies for bivalent dose if desired in 2-3 months from today. No adverse effects. All questions and concerns addressed.
I woke up with a fever and severe headache. The headache did not subside all day. Extreme nausea, fatigue, and pain at the injection site. Also chest pain that also radiated into the back of my body. I also experienced heart palpitations and a rapid heart rate. The pain in my chest is still present.
Pt received Pfizer vaccine. Needle malfunctioned and some of the vaccine came out around needle. Vaccinator reported that more than 1/2 of vaccine went into pt arm. Pt did not receive any additional vaccine. pt experienced no immediate ill effects
Developed slight fever 1 day after vaccination.  Developed rash on torso 2 days after vaccination which spread to arms and legs in the 3rd day after vaccination
No adverse effects known.  Administered monovalent when bivalent should have been administered.  Monovalent has just stopped being approved for use but was given instead of giving single bivalent.
Patient c/o metallic taste, chest tightness, SOB, difficulty breathing, and difficulty swallowing. Also had a mild erythematous rash. Symptoms began < 5 minutes after vaccination.  Epi Pen was administered and code team took patient to the emergency room. In the emergency room the patient  was treated with benadryl (50mg PO once), prednisone (60mg PO once), famotidine (20mg PO once)and monitored for 4 hours. Symptoms improved and patient was discharged home safely.
Pt woke up this morning, 5 days post vaccine, with rash on right arm, 3 lesions from 4x2 to 4x6cm, irregular borders, raised, slightly warm to touch, non-pruritic. Right arm has been sore since vaccination, no increase in pain today. Has tried ibuprofen but not helpful. Rx'd trial of cetirizine 10mg PO QD, will have her f/u in clinic in 2 days. Discussed importance of f/u sooner if sx's worsen. If she experiences troubles breathing, swelling of lips/tongue/throat will need to call 911/be seen in ER. Pt was seen at health clinic w/in school by physician assistant. PA called her mother and discussed plan as well. Both patient and mother understand and are agreeable to plan.
pt recvd vax 9OCT95 @ 10AM; nl exam @ that time;10hrs later temp sl elevated & irritable;26hrs still irritable-t101, not eating as well;sleepy;34hrs very lethargic, resp rapid;adm to hosp;dx diabetes mellitus-acidotic-re insulin
Since 4/4/2022, ongoing joint pain (knees, thumb, back, elbows), headache, head pressure, head fog (unable to alleviate symptoms with Tylenol or ibuprofen); and diarrhea (currently trying Imodium to alleviate). Hot flashes and extreme fatigue.
ongoing dull headache, eye/sinus pain, light headedness, and nausea approximately 5 minutes following 1st dose and ongoing 24 hours post dose.